Quick Answer
Wave Life Sciences Ltd. reported Net Income Loss of -$204.38 million for the year ending 2025.
- Wave Life Sciences Ltd. showed a decrease of -110.7% in Net Income Loss from 2024 to 2025.
- This data is from Wave Life Sciences Ltd.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), Wave Life Sciences Ltd.'s Net Income Loss has declined by 6,059.7%.
- Historical annual values: Fiscal year 2025: -$204.38 million | Fiscal year 2024: -$97.01 million | Fiscal year 2023: -$57.51 million | Fiscal year 2022: -$161.82 million | Fiscal year 2021: -$122.25 million | Fiscal year 2020: -$149.91 million | Fiscal year 2019: -$193.64 million | Fiscal year 2018: -$146.65 million | Fiscal year 2017: -$101.98 million | Fiscal year 2016: -$55.66 million | Fiscal year 2015: -$19.20 million | Fiscal year 2014: -$5.23 million | Fiscal year 2013: -$3.32 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: